Dialysis industry news

Stories from the dialysis comunity across the globe.



A Missense GATA3 Mutation, thr272ile, Causes the ... - Journal of Clinical Endocrinology and Metabolism PDF Print
Journal of Clinical Endocrinology and MetabolismContext: The hypoparathyroidism, deafness, renal dysplasia (HDR) syndrome is caused by mutations in the gene encoding GATA3, which belongs to a family of

... read more

 
PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, October 6 ... - Trading Markets (press release) PDF Print
Trading Markets (press release)Rockwell is a fully-integrated biopharmaceutical company offering innovative products and services initially targeting end-stage renal disease (ESRD),

... read more

 
PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts ... - Trading Markets (press release) PDF Print
Trading Markets (press release)Rockwell is a fully-integrated biopharmaceutical company offering innovative products and services initially targeting end-stage renal disease (ESRD),

... read more

 
Regorafenib shows a solid breakthrough in Renal Cancer - InjuryBoard.com (blog) PDF Print
InjuryBoard.com (blog)The findings are promising for renal cell carcinoma, the most common (about 90%) of all kidney cancers that challenge people in the 50 to 80 year old age

... read more

 
FDA unanimously recommends GSK's kidney cancer treatment - Drug Store News (blog) PDF Print
Drug Store News (blog)... Committee had voted unanimously to recommend approval for Votrient (pazopanib), an investigational pill-based treatment for renal cell carcinoma. ...GlaxoSmithKline Gets FDA Panel Recommendation For Kidney Cancer

... read more

 
<< Start < Prev 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 Next > End >>

Page 3570 of 4210
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.